WO2010061284A3 - A controlled release intravaginal polymeric pharmaceutical dosage form - Google Patents
A controlled release intravaginal polymeric pharmaceutical dosage form Download PDFInfo
- Publication number
- WO2010061284A3 WO2010061284A3 PCT/IB2009/007583 IB2009007583W WO2010061284A3 WO 2010061284 A3 WO2010061284 A3 WO 2010061284A3 IB 2009007583 W IB2009007583 W IB 2009007583W WO 2010061284 A3 WO2010061284 A3 WO 2010061284A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dosage form
- controlled release
- pharmaceutical dosage
- polymeric pharmaceutical
- release intravaginal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Abstract
This invention relates to a controlled release, intravaginal, pharmaceutical dosage form. The dosage form consists of at least one desired pharmaceutically active ingredient which is admixed with a combination of biocompatible and biodegradable polymers and shaped for insertion into the vagina of a patient. The polymers are selected so as to biodegrade at a predetermined rate and, on biodegrading, the pharmaceutically active ingredient is released.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AP2011005773A AP3204A (en) | 2008-11-30 | 2009-11-30 | A controlled release intravaginal polymeric pharmaceutical dosage form |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA2008/05077 | 2008-11-30 | ||
ZA200805077 | 2008-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010061284A2 WO2010061284A2 (en) | 2010-06-03 |
WO2010061284A3 true WO2010061284A3 (en) | 2010-10-28 |
Family
ID=42167983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/007583 WO2010061284A2 (en) | 2008-11-30 | 2009-11-30 | A controlled release intravaginal polymeric pharmaceutical dosage form |
Country Status (3)
Country | Link |
---|---|
AP (1) | AP3204A (en) |
WO (1) | WO2010061284A2 (en) |
ZA (1) | ZA200908494B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016056001A1 (en) | 2014-10-06 | 2016-04-14 | Algamed Therapeutics (A.M.T) Ltd | Compositions comprising sulfated polysaccharides and uses thereof |
EP3355893A4 (en) | 2015-09-29 | 2019-06-12 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
WO2006017238A1 (en) * | 2004-07-12 | 2006-02-16 | Umd, Inc. | Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea |
WO2007035515A2 (en) * | 2005-09-15 | 2007-03-29 | Umd, Inc. | A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration |
WO2007119185A2 (en) * | 2006-04-17 | 2007-10-25 | Kimberly-Clark Worldwide, Inc. | Degradable therapeutic delivery device |
-
2009
- 2009-11-30 AP AP2011005773A patent/AP3204A/en active
- 2009-11-30 WO PCT/IB2009/007583 patent/WO2010061284A2/en active Application Filing
- 2009-11-30 ZA ZA2009/08494A patent/ZA200908494B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416779B1 (en) * | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
WO2006017238A1 (en) * | 2004-07-12 | 2006-02-16 | Umd, Inc. | Coated vaginal device for delivery of anti-migraine and anti-nausea drugs and a method for treatment of migraine and nausea |
WO2007035515A2 (en) * | 2005-09-15 | 2007-03-29 | Umd, Inc. | A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration |
WO2007119185A2 (en) * | 2006-04-17 | 2007-10-25 | Kimberly-Clark Worldwide, Inc. | Degradable therapeutic delivery device |
Non-Patent Citations (1)
Title |
---|
NDESENDO V M K ET AL: "In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL LNKD- DOI:10.1016/J.IJPHARM.2008.12.001, vol. 370, no. 1-2, 31 March 2009 (2009-03-31), pages 151 - 159, XP026001820, ISSN: 0378-5173, [retrieved on 20081207] * |
Also Published As
Publication number | Publication date |
---|---|
AP2011005773A0 (en) | 2011-06-30 |
AP3204A (en) | 2015-03-31 |
ZA200908494B (en) | 2010-12-29 |
WO2010061284A2 (en) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010062523A3 (en) | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof | |
WO2007038246A3 (en) | Solid polymer delivery compositions and methods for use thereof | |
WO2006023130A3 (en) | Biodegradable controlled release bioactive agent delivery device | |
NZ603579A (en) | Controlled release formulations | |
WO2008098927A3 (en) | Degradable reservoir implants | |
WO2009094573A3 (en) | Linear order release polymer | |
WO2006039336A3 (en) | Conveniently implantable sustained release drug compositions | |
WO2008070356A3 (en) | Block biodegradable copolymers for medical devices | |
WO2008014191A3 (en) | Apparatus and method for manipulating or retracting tissue and anatomical structure | |
WO2010005723A3 (en) | Drug loaded polymeric nanoparticles and methods of making and using same | |
WO2012018446A3 (en) | Anchor delivery system | |
WO2007036952A3 (en) | Novel sustained release dosage form | |
WO2011031855A3 (en) | Implantable device for controlled drug delivery | |
WO2008087488A3 (en) | Expandable medical device for the treatment and prevention of cardiovascular diseases | |
WO2010061288A3 (en) | Polymeric pharmaceutical dosage form in sustained release | |
WO2009005909A3 (en) | Biodegradable triblock copolymers for implantable devices | |
WO2007130134A3 (en) | Controlled release microparticles | |
WO2006083904A3 (en) | Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility | |
WO2007133924A3 (en) | Biodegradable modified caprolactone polymers for fabricating and coating medical devices | |
WO2009048594A3 (en) | Multicomponent bioactive intravaginal ring | |
WO2008054772A3 (en) | Implantable elastomeric caprolactone depot compositions and uses thereof | |
MX2009005445A (en) | Delivery system for risperidone. | |
WO2011139595A3 (en) | Elongated biodegradable depot for sustained drug release to treat chronic pelvic pain | |
WO2005000268A3 (en) | Bioerodible sustained release drug delivery systems | |
WO2011112996A3 (en) | Injectable drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09793573 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09793573 Country of ref document: EP Kind code of ref document: A2 |